SRS histopathology

Cancer is among the main causes for death in the EU. According to Eurostat more than 350,000 cancer-related surgeries in Germany and France were carried out in 2016 only. All surgeries face the same challenge: Was all cancerous tissue removed from the patient?

Answering this question reliably during the surgery itself is vital, but unfortunately not possible today. The SRHisto project aims at overcoming this challenge by developing a label free technology to provide real time images of cancerous tissue directly in the operatory room.

Conventional HES (haematoxylin, eosin and saffron) histopathology, currently the ‘gold-standard’ for pathological diagnosis of cancer, requires extensive sample preparations that are achieved within time scales (<24h) that are not compatible with intra-operative situations where quick decisions must be taken.

Read more…

Published by Attract